Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04490863 · ClinicalTrials.gov registry record · NA

Noninvasive Hemoglobin Repeatability and Reproducibility in a Blood Donation Setting

A NA study of Healthy and Anemia, sponsored by Masimo Corporation.

Completed
Registry status
NA
Development phase
26
Enrollment target
1
Study location

NCT04490863 is a NA study of Healthy and Anemia that has completed, run by Masimo Corporation. The registered enrollment target is 26 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04490863, a NA study of Healthy and Anemia, has completed, sponsored by Masimo Corporation.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this clinical investigation is to report on the repeatability and reproducibility of SpHb measurements from Rad-67 devices and DCI Mini sensors used to screen prospective blood donors at a donation center.

Conditions Studied

Interventions

  • DEVICE Rad-67 Pulse oximeter & DCI Mini sensor

Study Locations (1)

California

  • Blood Bank - Site 1 - San Diego

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2020-07-16
Est. Completion 2020-08-20
Phase NA

Sponsor

Masimo Corporation

96 total trials

What the Registry Record Tells You About NCT04490863

The ClinicalTrials.gov registry entry for NCT04490863 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Rad-67 Pulse oximeter & DCI Mini sensor is the first listed.

NCT04490863 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04490863 about?

NCT04490863 is a clinical study titled "Noninvasive Hemoglobin Repeatability and Reproducibility in a Blood Donation Setting". The primary objective of this clinical investigation is to report on the repeatability and reproducibility of SpHb measurements from Rad-67 devices and DCI Mini sensors used to screen prospective blood donors at a donation center.

What is the current status of trial NCT04490863?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2020-07-16. Estimated completion is 2020-08-20.

What conditions does trial NCT04490863 study?

This clinical trial studies the following conditions: Healthy, Anemia.

What interventions are being tested in trial NCT04490863?

The interventions under investigation include: Rad-67 Pulse oximeter & DCI Mini sensor (DEVICE).

Who is sponsoring clinical trial NCT04490863?

This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04490863 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.